YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
DUBLIN, October 08, 2026--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading clinical research organization, today announced that it will release its financial results for the third quarter 2026 after the market closes on Tuesday, O…
Marram Investment Management's second-quarter 2026 investor letter reports a +2.7% portfolio return (net of fees), resulting in a year-to-date return of +3.2%. A copy of the letter can be downloaded here. Cumulatively, since inception, the…
A month has gone by since the last earnings report for CVS Health (CVS). Shares have added about 1% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading up to its next earnings release, or is CVS H…
It has been about a month since the last earnings report for Icon PLC (ICLR). Shares have added about 2.5% in that time frame, underperforming the S&P 500. Will the recent positive trend continue leading up to its next earnings release, or…
DUBLIN, August 20, 2026--(BUSINESS WIRE)--ICON plc (NASDAQ: ICLR) ("ICON"), a world-leading clinical research organisation, today releases its ICON Cares 2025 Report which outlines how the company is delivering on its environmental, social…
During these busy times, it pays to stay on top of the latest profit opportunities. And today's blog post should be a great place to start. After taking a close look at the latest data on institutional buying pressure and each company's fu…
ICON Public Limited Company ICLR presents a mixed investment case. The stock trades below several key benchmarks, while new business awards and backlog point to healthier commercial demand. That opportunity is tempered by weaker earnings e…
Medpace Holdings, Inc. MEDP combines double-digit earnings growth, resilient profitability and improving bookings with a valuation far above industry and market levels. The central question is whether its operating quality and 2027 pipelin…
* ICON (ICLR [https://seekingalpha.com/symbol/ICLR]) priced a $2.15B offering of senior unsecured notes through its wholly owned subsidiary, consisting of $500M of 5.064% notes due 2029, $1B of 5.421% notes due 2031, and $650M of 5.995% no…
DUBLIN, August 06, 2026--(BUSINESS WIRE)--ICON plc (NASDAQ: ICLR) ("ICON"), a world-leading clinical research organization, today announced the pricing by its wholly-owned subsidiary, ICON Investments Six Designated Activity Company (the "…
Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. ICON and Anthropic announced a multi year collaboration to integrate AI across the clinical trial…
ICON Public Limited Company ICLR shares have gained 33.2% in the past three months, reflecting renewed confidence in a recovery despite lingering earnings and internal-control risks. Improving proposal activity and bookings support that op…
Medpace Holdings, Inc. MEDP regained commercial momentum in the second quarter of 2026 as record awards and a higher book-to-bill ratio reversed the weaker first-quarter trend. The central issue is timing. Better demand can strengthen back…
IQVIA Holdings Inc. IQV is benefiting from stronger demand across clinical research and commercial services, supported by data assets that are difficult to replicate. The investment case is less straightforward on the balance sheet. High d…
Greenskeeper Asset Management, an independent firm that specializes in disciplined value investing, recently released its Q2 2026 scorecard. A copy is available to download here. After a slow start to the year, the Fund gained 10.9% in the…
IQVIA Holdings Inc. IQV shares climbed 13% in a week as investors weighed better-than-expected quarterly results, stronger bookings and a raised full-year outlook. The move reflects improving operating momentum, but its durability depends…
DUBLIN, August 04, 2026--(BUSINESS WIRE)--ICON plc (NASDAQ: ICLR) ("ICON"), a world-leading clinical research organization, announced today that its wholly-owned subsidiary, ICON Investments Six Designated Activity Company (the "Issuer"),…
DUBLIN, July 31, 2026--(BUSINESS WIRE)--ICON plc(NASDAQ: ICLR), a world-leading clinical research organization, today announced that all resolutions at the Annual General Meeting of the company (AGM) held on July 31, 2026 were duly passed…
This article first appeared on GuruFocus. Revenue: $2.1 billion, up 1.2% year-over-year and 1.4% sequentially. Adjusted EBITDA: $327 million, with a margin of 15.9%. Adjusted EPS: $2.56. Adjusted Gross Margin: 23.8%, compared to 29.1% in Q…
Icon PLC (ICLR) came out with quarterly earnings of $2.56 per share, missing the Zacks Consensus Estimate of $2.57 per share. This compares to earnings of $3.26 per share a year ago. These figures are adjusted for non-recurring items. This…
Highlights Quarter two revenue of $2,063.5 million, an increase of 1.4% on quarter one 2026. Quarter two adjusted EBITDA of $327.2 million or 15.9% of revenue, an increase of 3.0% on quarter one 2026. GAAP net income for the quarter of $72…
Harris Oakmark recently released its second-quarter 2026 investor letter for the "Oakmark U.S. Concentrated Strategy". A copy of the letter can be downloaded here. The strategy returned 9.21% (net) in the second quarter, lagging the Russel…
(RTTNews) - Tuesday, ICON Public Limited Company (ICLR) announced a multi-year collaboration with Anthropic to integrate Claude's AI capabilities across the clinical trial lifecycle, further advancing its AI platform Orbis. Under this, the…
DUBLIN, July 28, 2026--(BUSINESS WIRE)--ICON plc (NASDAQ: ICLR) today announced a multi-year collaboration with Anthropic to bring Claude's AI capabilities across the clinical trial lifecycle. The collaboration further advances ICON's digi…
It has been about a month since the last earnings report for Icon PLC (ICLR). Shares have added about 5.8% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading up to its next earnings release, or i…
City Different Investments, an investment management firm, released Q2 2026 investor update for its global equity strategies. A copy of the letter can be downloaded here. City Different global equity strategies delivered strong results in…
DUBLIN, July 22, 2026--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading clinical research organization, today announced that it will release its financial results for the second quarter 2026 after the market closes on Wednesday, J…
Investors interested in stocks from the Medical Services sector have probably already heard of Avantor, Inc. (AVTR) and Icon PLC (ICLR). But which of these two stocks is more attractive to value investors? We'll need to take a closer look…
The market expects Icon PLC (ICLR) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended June 2026. This widely-known consensus outlook is important in assessing the company's earni…
NEW YORK, July 09, 2026 (GLOBE NEWSWIRE) -- Moore Law, PLLC, a shareholder litigation law firm located on Wall Street, is investigating: ICON plc (NASDAQ: ICLR) shareholders should email fletcher@fmoorelaw.com What is the Investigation Abo…
Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. ICON stock sits at an unusual valuation crossroads, with a Discounted Cash Flow (DCF) intrinsic value estimate pointing to a…
ICON plc ICLR sits where several healthcare investment themes meet. Sponsor demand for outsourced clinical development, biotech funding, artificial intelligence and broader site access all support the company's long-term positioning. The i…
Artisan Partners, an investment management firm, issued its first-quarter 2026 investor letter for the "Artisan Mid Cap Value Fund". A copy of this letter is available for download here. In Q1 2026, the portfolio underperformed the benchma…
ICON plc ICLR is facing a classic recovery-stock test. The valuation has compressed, bookings have improved and backlog is larger. The problem is that the earnings reset is not over. Investors still have to weigh better order flow against…
ICON plc ICLR enters the second half of 2026 with an uneven investment profile. Customer demand signals improved in the latest quarter, but the operating model has not yet shown a clean recovery. That split matters for investors weighing t…
During these busy times, it pays to stay on top of the latest profit opportunities. And today's blog post should be a great place to start. After taking a close look at the latest data on institutional buying pressure and each company's fu…